StockData
CG Oncology, Inc. logo

CG Oncology, Inc. (CGON) stock

CGONNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$78.94−5.84 (-6.89%)

Close on Nov 17, 2026Market cap $7.00BP/E –Yield –

CG Oncology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

CG Oncology's market cap was $6.41B on Nov 11, 2026, against $3.51B a year earlier. Over the last 3 years it ranged from $209.88M to $6.64B, with a median of $2.46B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$6.41B+97.3%
2025Dec 31, 2025$3.25B+67.8%
2024Dec 31, 2024$1.94B–

More CG Oncology figures

See a number that looks wrong?